IBDEI36G ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,53349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53349,1,3,0)
 ;;=3^Hydrocele, unspecified
 ;;^UTILITY(U,$J,358.3,53349,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,53349,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,53350,0)
 ;;=N52.9^^245^2682^10
 ;;^UTILITY(U,$J,358.3,53350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53350,1,3,0)
 ;;=3^Male erectile dysfunction, unspecified
 ;;^UTILITY(U,$J,358.3,53350,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,53350,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,53351,0)
 ;;=L03.031^^245^2683^3
 ;;^UTILITY(U,$J,358.3,53351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53351,1,3,0)
 ;;=3^Cellulitis of right toe
 ;;^UTILITY(U,$J,358.3,53351,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,53351,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,53352,0)
 ;;=L03.032^^245^2683^2
 ;;^UTILITY(U,$J,358.3,53352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53352,1,3,0)
 ;;=3^Cellulitis of left toe
 ;;^UTILITY(U,$J,358.3,53352,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,53352,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,53353,0)
 ;;=L03.90^^245^2683^4
 ;;^UTILITY(U,$J,358.3,53353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53353,1,3,0)
 ;;=3^Cellulitis, unspecified
 ;;^UTILITY(U,$J,358.3,53353,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,53353,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,53354,0)
 ;;=L08.9^^245^2683^16
 ;;^UTILITY(U,$J,358.3,53354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53354,1,3,0)
 ;;=3^Skin infection, unspec
 ;;^UTILITY(U,$J,358.3,53354,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,53354,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,53355,0)
 ;;=L29.9^^245^2683^9
 ;;^UTILITY(U,$J,358.3,53355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53355,1,3,0)
 ;;=3^Pruritus, unspecified
 ;;^UTILITY(U,$J,358.3,53355,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,53355,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,53356,0)
 ;;=L30.9^^245^2683^5
 ;;^UTILITY(U,$J,358.3,53356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53356,1,3,0)
 ;;=3^Dermatitis, unspecified
 ;;^UTILITY(U,$J,358.3,53356,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,53356,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,53357,0)
 ;;=L40.0^^245^2683^10
 ;;^UTILITY(U,$J,358.3,53357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53357,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,53357,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,53357,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,53358,0)
 ;;=L40.1^^245^2683^13
 ;;^UTILITY(U,$J,358.3,53358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53358,1,3,0)
 ;;=3^Pustular psoriasis, generalized
 ;;^UTILITY(U,$J,358.3,53358,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,53358,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,53359,0)
 ;;=L40.2^^245^2683^1
 ;;^UTILITY(U,$J,358.3,53359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53359,1,3,0)
 ;;=3^Acrodermatitis continua
 ;;^UTILITY(U,$J,358.3,53359,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,53359,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,53360,0)
 ;;=L40.3^^245^2683^14
 ;;^UTILITY(U,$J,358.3,53360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53360,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,53360,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,53360,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,53361,0)
 ;;=L40.4^^245^2683^11
 ;;^UTILITY(U,$J,358.3,53361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53361,1,3,0)
 ;;=3^Psoriasis, guttate
 ;;^UTILITY(U,$J,358.3,53361,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,53361,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,53362,0)
 ;;=L40.8^^245^2683^12
 ;;^UTILITY(U,$J,358.3,53362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53362,1,3,0)
 ;;=3^Psoriasis, other
